Patients like me manage lifelong illness with cannabis. For us the UK is a...
As a 30 year old with Crohns disease I have lived my entire adult life dependent on drugs both legal and illegal. I have learnt what works best to keep my symptoms under control and provide me...
View ArticleSandoz receives European Commission approval for biosimilar Hyrimoz adalimumab
Novartis International AG Sandoz receives European Commission approval for biosimilar Hyrimoz adalimumab . Processed and transmitted by Nasdaq Corporate Solutions.The issuer is solely responsible for...
View ArticleOncobiologics Inc ONS Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryOncobiologics Inc Oncobiologics is a clinical stage biopharmaceutical company that develops and markets biosimilar therapeutics. The company's pipeline products comprise ONS3010 and ONS1045. It...
View ArticleTrivedi Global Inc. and Mark Stutheit Announce Preclinical Research of...
Over 50 improvement in overall immunity.OMAHA Neb. PRWEB July 28 2018 Mark Stutheit a scientifically validated energy healer today announces the impact of a biofield energy treated proprietary...
View ArticleTrivedi Global Inc. with Inthirani Arul Announce Research Results on the...
112 increase in expression of humoral immune response. The research findings suggest that the biofield energy treatment improved the nutraceutical&39;s antiinflammatory and immunomodulatory...
View ArticleMycenax Biotech Inc 4726 Pharmaceuticals Healthcare Deals and Alliances...
SummaryMycenax Biotech Inc Mycenax is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates...
View ArticleInnovent Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryInnovent Biologics Inc Innovent Biologics is a biopharmaceutical company that discovers develops and manufactures monoclonal antibodies. The company's product portfolio comprise monoclonal...
View ArticleInDex Pharmaceuticals Holding AB INDEX Pharmaceuticals Healthcare Deals and...
SummaryInDex Pharmaceuticals Holding AB InDex Pharmaceuticals is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct...
View ArticleArena Pharmaceuticals Inc ARNA Financial and Strategic SWOT Analysis Review...
Arena Pharmaceuticals Inc ARNA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleMicrobiomeTargeted Therapeutics in Immunology Report Updated 28032018 Prices...
MicrobiomeTargeted Therapeutics in ImmunologySummaryFlares in gastrointestinal and dermatology indications are characterized by a shift in the proportion of bacterial species in either the gut or skin...
View ArticleTyrosine Protein Kinase JAK2 Janus Kinase 2 or JAK2 or EC 2.7.10.2 Pipeline...
Tyrosine Protein Kinase JAK2 Janus Kinase 2 or JAK2 or EC 2.7.10.2 Pipeline Review H1 2018SummaryTyrosine Protein Kinase JAK2 Janus Kinase 2 or JAK2 or EC 2.7.10.2 Janus kinase 2 is a nonreceptor...
View ArticleTrivedi Global Inc. and Dr. William Plikerd Announce Research on Impact of a...
Overall immunity increased by over 250. The research findings suggest that the biofield energy treatment enhanced the nutraceutical&39;s antiinflammatory and immunomodulatory properties.COLUMBUS...
View ArticleTrivedi Global Inc. and SuMei Liu Announce Research on the Impact of a...
Overall immunity increased by over 250.OAKLAND Calif. PRWEB July 29 2018 SuMei Liu an evidencebased energy healer today announces research based on the impact of a biofield energy treated nutraceutical...
View ArticleRedHill Biopharmas Crohns Drug Shows Promise for Disease Remission
RedHill Biopharma with offices in Tel Aviv Israel and Raleigh North Carolina announced positive topline data from its first Phase III trial of RHB104 for Crohns disease. It met all primary endpoint and...
View ArticleRedHill BioPharma has positive results from Crohn's disease trial
Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a latestage clinical trial with its treatment for Crohn's disease called RHB104.
View Article4D Announces Publication of Data Showing Potential of Single Bacterial...
LEEDS United Kingdom July 30 2018 GLOBE NEWSWIRE 4D pharma plc AIMDDDD a pharmaceutical company leading the development of live biotherapeutics today announces the publication of data showing that...
View ArticleRedHill drug for Crohn's clears first Phase 3 hurdle
RHB104 is a combo of three antibiotics designed to attack a bacterial infection that&39;s thought to play a role in Crohn&39;s.
View ArticleEU Commission grants market authorisation for Sandoz Humira biosimilar
The European Commission has granted marketing authorisation to Sandoz biosimilar Hyrimoz for use in all indications including rheumatoid arthritis plaque psoriasis Crohn's disease uveitis and...
View ArticleStellar success showcased in The Times SuperNorth published today
The front page signals a clear call to action to the Government to unlock opportunities to deliver growth voiced by a delegation including Bionow Members in a round table discussion chaired by the...
View ArticleSublimity Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances...
SummarySublimity Therapeutics LtdSublimity formerly known as Sigmoid Pharma Ltd focuses on the development of therapeutics for unmet clinical needs in gastrointestinal and immunological diseases and...
View Article